The prophylactic administration of itopride can decrease the risk of nausea in patients receiving lubiprostone and consequently reduce the risk of treatment discontinuation.
The prophylactic administration of itopride can decreasethe risk of nausea in patients receiving lubiprostone and consequently reduce the risk of treatmentdiscontinuation.